Latest News

Flagstar Bank: Still Avoiding Common And Preferred Shares
Flagstar Bank faces persistent headwinds, with nonperforming assets and declining net interest income impairing earnings growth. FLG's Series A preferred shares yield 6.7%, below peer averages, and ar

monday.com: Workforce Reduction Paves The Way For Profit Growth And Lower Dilution
monday.com remains in a deep bear market, down over 50% in the past year despite broader software sector recovery. The company recently announced a layoff of 20% of its staff in July, which will help

The Outlook For S&P 500 Dividends In August 2026
The dividend outlook of the S&P 500 once again delivered a mixed outlook for investors in August 2026. Expected dividends for the index dipped in the current quarter of 2026-Q3, but the amount of cash

Kaplan Fox Alerts Investors of a Securities Class Action Against PROCEPT BioRobotics Corporation (PRCT) - Deadline is September 22, 2026
New York, New York--(Newsfile Corp. - August 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "Com

Is Nike stock a buy after 80% crash from all-time high?
Nike (NYSE: NKE) stock has fallen another 4%, trading at $39.06 at the time of writing on August 18, a level that marks a new 52-week low and the lowest intraday level in roughly 12 years.

2Q26 Midstream/MLP Buybacks: Momentum Continues
Quarterly equity repurchases for midstream MLPs and corporations remained healthy in 2Q26, keeping pace with first-quarter levels. Cheniere Energy (LNG) spent $550 million on buybacks, and familiar pl

Pfizer: Still Cheap Valuation Meets A Looming Patent Cliff
Pfizer remains a cautious Buy, trading near intrinsic value with an expected 10% annual return, primarily from its high dividend yield. PFE faces significant headwinds: a looming patent cliff, a stret

Can-Am Commits to the Future of Off-Road Innovation With Two Visionary Concept Builds: the Defender Prerunner and the Maverick R XRay
The Can-Am Defender Prerunner revolutionizes race support vehicle capability The Can-Am Maverick R XRay turns the Maverick R into a light show in the dunes Can-Am to release major off-road product ann

Wall Street Breakfast Podcast: Return Of The Bond Vigilantes?
U.S. 30-year Treasury yield (US30Y) has surged to 5.33%, its highest since 2007, reflecting rising concerns about government debt and inflation. Strategists and analysts question whether 30-year bonds

Apple Says Antitrust Issues Are Hurting Services Business
Apple says antitrust battles around its App Store are weighing on its services business. The tech giant acknowledged the issue in its most recent filing with the Securities and Exchange Commission (SE

Jaguar Uranium Reports Final Copper Assay Results Including up to 8.54% Copper, Potential 4-km Trend Identified from Huemul Uranium-Copper-Vanadium Project
Channel and rock chip samples from areas of visible uranium-copper-vanadium mineralization observed at surface returned final assay results for copper (up to 8.54%), uranium (up to 2.27%), silver (up

Pro Medicus Limited (PMDIY) Q4 2026 Earnings Call Transcript
Pro Medicus Limited (PMDIY) Q4 2026 Earnings Call Transcript

Swarmer: Taking A Small Stake Here As The Growth Plan Becomes More Clear
Swarmer is a high-margin SaaS play targeting the autonomous drone market, with a unique software-only business model. Despite a recent earnings miss, SWMR maintains strong growth prospects, aiming for

YYY: The Income Is Attractive, The Long-Term Returns Are Not
The Amplify CEF High Income ETF offers a 12.81% distribution rate, but its 10-year NAV total return is only 5.11% annualized. Several major credit-oriented holdings use substantial leverage, while tig

New Mountain Finance: 29% NAV Discount And Stock Buybacks Create Opportunity
New Mountain Finance remains a 'Buy' despite a 22% dividend cut and a 24% portfolio contraction year-over-year. The dividend reset to $0.25 per share restored dividend coverage to 104% in Q2, mitigati

Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 18, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has been filed after it

PRIM INVESTOR ALERT: Primoris Services Corporation Investors with Substantial Losses Have Opportunity to Lead the Primoris Class Action Lawsuit
SAN FRANCISCO, Aug. 18, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Primoris Services Corporation (NYSE: PRIM) that securities class action lawsuit has been filed against

CCOI INVESTOR DEADLINE: Cogent Communications Holdings Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
SAN FRANCISCO, Aug. 18, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Cogent Communications Holdings (NASDAQ: CCOI) that a securities class action has been filed after quest

Goldman Sachs Is Still The Bank To Buy
Goldman Sachs is rated a 'buy' due to scale, deal flow leadership, and a resilient capital formation cycle. GS's Q2 net revenues rose to $20.34Bn, with 23.5% ROE and $6.63Bn net earnings, driven by G

PRCT INVESTOR ALERT: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN FRANCISCO, Aug. 18, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after repe